1. |
Botulinum Toxins, Type A
|
cell cycle
|
|
Botulinum Toxins, Type A affects cell cycle |
1: Homo sapiens |
Fibroblasts | Cells, Cultured |
|
1 |
2. |
Botulinum Toxins, Type A
|
locomotion
|
|
Botulinum Toxins, Type A results in increased locomotion |
1: Homo sapiens |
|
|
1 |
3. |
Botulinum Toxins, Type A
|
spontaneous synaptic transmission
|
|
Botulinum Toxins, Type A results in decreased spontaneous synaptic transmission |
1: Homo sapiens |
Induced Pluripotent Stem Cells | Neurons |
|
1 |
4. |
Botulinum Toxins, Type A
|
spontaneous synaptic transmission
|
|
Botulinum Toxins, Type A results in decreased spontaneous synaptic transmission |
1: Rattus norvegicus |
Cerebellum | Neurons |
|
1 |
5. |
Botulinum Toxins, Type A
|
spontaneous synaptic transmission
|
|
Botulinum Toxins, Type A results in decreased spontaneous synaptic transmission |
1: Mus musculus |
Mouse Embryonic Stem Cells | Neurons |
|
1 |
6. |
Botulinum Toxins, Type A
|
spontaneous neurotransmitter secretion
|
|
Botulinum Toxins, Type A results in decreased spontaneous neurotransmitter secretion |
1: Mus musculus |
Mouse Embryonic Stem Cells | Neurons |
|
1 |
7. |
Botulinum Toxins, Type A
|
acetylcholine secretion, neurotransmission
|
|
Botulinum Toxins, Type A results in decreased acetylcholine secretion, neurotransmission |
1: Mus musculus |
Diaphragm | Motor Endplate |
|
1 |
8. |
Botulinum Toxins, Type A
|
locomotion
|
|
Botulinum Toxins, Type A results in decreased locomotion |
1: Mus musculus |
Leg | Muscle, Skeletal |
|
1 |
9. |
Botulinum Toxins, Type A
|
locomotion
|
|
Botulinum Toxins, Type A analog results in decreased locomotion |
1: Mus musculus |
Leg | Muscle, Skeletal |
|
1 |
10. |
Botulinum Toxins, Type A
|
diaphragm contraction
|
|
Botulinum Toxins, Type A results in decreased diaphragm contraction |
1: Mus musculus |
Diaphragm |
|
1 |
11. |
Botulinum Toxins, Type A
|
diaphragm contraction
|
|
Botulinum Toxins, Type A analog results in decreased diaphragm contraction |
1: Mus musculus |
Diaphragm |
|
1 |
12. |
rimabotulinumtoxinB
|
skeletal muscle contraction
|
|
rimabotulinumtoxinB results in increased skeletal muscle contraction |
1: Mus musculus |
Muscle, Skeletal |
|
1 |
13. |
rimabotulinumtoxinB
|
spontaneous synaptic transmission
|
|
rimabotulinumtoxinB results in decreased spontaneous synaptic transmission |
1: Homo sapiens |
Induced Pluripotent Stem Cells | Neurons |
|
1 |
14. |
rimabotulinumtoxinB
|
spontaneous synaptic transmission
|
|
rimabotulinumtoxinB results in decreased spontaneous synaptic transmission |
1: Rattus norvegicus |
Cerebellum | Neurons |
|
1 |
15. |
rimabotulinumtoxinB
|
spontaneous synaptic transmission
|
|
rimabotulinumtoxinB results in decreased spontaneous synaptic transmission |
1: Mus musculus |
Mouse Embryonic Stem Cells | Neurons |
|
1 |
16. |
rimabotulinumtoxinB
|
spontaneous neurotransmitter secretion
|
|
rimabotulinumtoxinB results in decreased spontaneous neurotransmitter secretion |
1: Mus musculus |
Mouse Embryonic Stem Cells | Neurons |
|
1 |
17. |
rimabotulinumtoxinB
|
locomotion
|
|
rimabotulinumtoxinB analog results in decreased locomotion |
1: Mus musculus |
Leg | Muscle, Skeletal |
|
1 |
18. |
rimabotulinumtoxinB
|
diaphragm contraction
|
|
rimabotulinumtoxinB analog results in decreased diaphragm contraction |
1: Mus musculus |
Diaphragm |
|
1 |